Bio-Rad reported last week that board member Philip Padou has died at the age of 72.
 
Padou joined Bio-Rad’s Board in 1980, and he was VP and CFO of Ozier Perry and Associates until his retirement in 1991.
 
David Schwartz, chairman of Bio-Rad’s board, said in a statement that Padou was “a dedicated and valuable member” of the board.
 
The company said it will begin seeking a replacement for Padou as soon as possible.
 

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.